FDA Forces Recall of Nara Organics Infant Formula Following Multistate Botulism Outbreak

For parents, the pantry is supposed to be a safe haven of nourishment, and trusting the formula you mix for your baby is a fundamental part of daily life. That trust has been fractured this week as the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention forced a nationwide recall of Nara Organics Whole Milk Organic Powdered Infant Formula following a multistate outbreak of infant botulism. Four infants, ranging in age from two to five months, have been hospitalized across California, Pennsylvania, and Washington after consuming the European-manufactured product. The illnesses, which began between April and May 2026, prompted federal regulators to intervene after epidemiological data linked all four cases directly to the Nara Organics formula. The recall marks a significant escalation in ongoing federal efforts to secure the infant formula supply chain against rare but severe bacterial contaminants, forcing families to double-check their shelves and rethink their feeding plans.[1][2][4]

If you have a can of Nara Organics in your kitchen right now, federal health officials are urging you to stop using it immediately. The sweeping recall affects all lots of the formula, which was distributed nationally through Target retail locations, Target.com, and the company's own website between July 2025 and June 2026. In a departure from typical recall advice, the FDA is asking parents not to simply toss opened containers into the trash. Instead, grab a marker, clearly label the can 'DO NOT USE,' and tuck it away in a safe cupboard for at least a month. State health departments may need to collect that leftover powder for laboratory testing if an infant subsequently develops symptoms. Unopened cans, however, should be returned to the place of purchase or thrown away immediately to ensure they do not accidentally end up in a baby's bottle.[1][2][5]

The reality of infant botulism is frightening for any caregiver to picture, making immediate vigilance essential. The illness is a rare but potentially fatal condition that strikes children under the age of one, whose delicate gut microbiomes are not yet mature enough to fend off certain bacterial invaders. The condition develops when an infant ingests Clostridium botulinum spores, which then colonize the intestinal tract and produce a powerful neurotoxin. The onset of the illness is often insidious, typically beginning with severe constipation before progressing to decreased facial expression, poor feeding, drooping eyelids, and a loss of head control. If left untreated, the toxin causes progressive descending muscle weakness that can lead to respiratory arrest. All four infants in the current outbreak required hospitalization and treatment with BabyBIG, a specialized intravenous medication derived from the blood plasma of immunized donors.[2][3][4]

The outbreak has exposed a hidden vulnerability in how the food industry processes the dairy ingredients that eventually reach your baby's bottle. Unlike Cronobacter and Salmonella—the pathogens that modern infant formula safety protocols were primarily designed to detect—Clostridium botulinum forms highly resilient spores. These microscopic spores are capable of surviving standard liquid pasteurization and the intense heat of the spray-drying processes used to convert liquid milk into powder. Because standard indicator tests used in dairy processing do not routinely screen for botulinum spores, contaminated whole milk powder can easily pass through the supply chain undetected, arriving at manufacturing facilities and ultimately ending up in consumer packaging.[7][8]

This unsettling incident represents the second time in less than a year that a premium organic whole milk formula has been linked to a botulism outbreak, following a similar crisis involving ByHeart formula in late 2025. Federal investigations have revealed a startling supply chain overlap: both Nara Organics and ByHeart reportedly sourced their organic whole milk from the same supplier and utilized the identical spray-drying facility. In response to these repeated failures, the FDA issued a formal letter to the infant formula industry in mid-July 2026, demanding that manufacturers take far greater responsibility for vetting the ingredients they purchase. The agency emphasized that companies must rigorously track where ingredients originate, how they are processed, and whether specific pathogen risks are adequately controlled before mixing them into infant food.[7][8]

Perhaps the most frustrating aspect for families is the persistent challenge of clearing recalled products from neighborhood store shelves before they end up in shopping carts. During the previous ByHeart recall, FDA inspectors conducted over 4,000 retail checks and discovered that the recalled formula remained available for purchase at more than 175 locations across 36 states weeks after the initial alert. In some alarming instances, the recalled product was offered at a discounted promotional price days after the recall expanded, and customer returns were mistakenly placed back on store shelves. Food safety advocates warn that these preventable retail failures place the most vulnerable population—infants who rely on formula as their sole source of nutrition—at continued risk of severe illness long after a recall is announced.[6]

The fallout from the Nara Organics outbreak has already moved from the kitchen to the courtroom, intensifying regulatory scrutiny on the brand. A lawsuit filed on behalf of the hospitalized Pennsylvania infant alleges that the company marketed its use of powdered whole milk as a premium, natural feature while failing to disclose the well-documented risks of spore contamination to parents. The FDA noted that prior to the outbreak, it had inspected the two European facilities that manufacture the Nara Organics formula and issued observations citing operational deficiencies. Both facilities have reportedly submitted corrective action plans that are currently under federal review, while laboratory testing of unopened formula samples continues in an effort to pinpoint the exact source of the contamination.[8]

Despite the severity of the illnesses and the nationwide scope of the recall, federal officials are working to reassure families planning their weekly grocery runs. Nara Organics is a niche, premium brand that accounts for less than 1% of all infant formula sold in the United States. Consequently, the FDA and CDC do not anticipate that this recall will trigger the kind of widespread formula shortages that have plagued parents in recent years. Nevertheless, the outbreak serves as a stark reminder of the fragile nature of infant nutrition supply chains and the devastating consequences when ingredient oversight and retail enforcement fall short of the standards required to protect the youngest consumers.[2][5]